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2212-0661/© 2016 The Authors. Published by Elsevier B.Va b s t r a c tClinical genetics has wrestled with the problem of misattributed paternity for decades. While there are no clear
directives on policy, surveys suggest that genetics professionals are inclined to avoid disclosure when possible.
Changes associated with the increased use of genomic testing will alter the context and may limit the beneﬁts
of non-disclosure. Multi-site testing will preclude the uncertainty often associated with single-gene testing.
Increased use of genetic testing in clinical and non-clinical settings will create new opportunities for the
subsequent unmasking ofmisattributed relationships, aswill the presence of test results in the electronicmedical
record. Family health history information will becomemore valuable as it is usedmore often and to better effect
in risk assessment, diagnosis, treatment and reproductive decision-making. These changes associated with
genomic testing increase the risks and decrease the beneﬁts associated with the nondisclosure of misattributed
paternity. For ethical and practical reasons, genetics professionals, and thosewho advise them, should consider a
greater emphasis on the value of carefully planned disclosure.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
There is nothing newabout the problemofmisattributed paternity; it is
biblically old. The unmasking of it via genetic testing produces a clinical di-
lemma thatpits thevalueof truthfulness andourduty to informagainst our
profound disinclination to disrupt relationships within a family. While this
conﬂict remains, its context is changing rapidly due to developments on at
least three fronts. First, multi-site and genomic tests identify misattributed
relationships with greater certainty than the single-gene tests that predate
them. Second, a steady increase in the use of genetic testing in and out of
clinical settings makes it more likely that misattributed relationships will
be uncovered, and more likely that they will be uncovered subsequently
if not revealed at the time of testing. Third, improvements in our ability
to use family healthhistory information in risk assessment, diagnosis, treat-
ment and reproductive decision-making raise the stakes on nondisclosure.
All of these changes force us to take a new look at an old problem as we
transition into the post-genomic era.
2. The status quo: a de facto policy of non-disclosure
The discovery of misattributed biological relationships as a result of
clinical genetic testing can take several forms. For example, single-nH.Marks Graduate Program in
ted States.
. This is an open access article undernucleotide polymorphism (SNP) arrays can reveal parental consanguin-
ity, whichmay be unknown tomembers of a family (Helm et al., 2014).
Revelations about misattributed maternity may also increase in
frequency asmore couples opt to conceive using donor eggs or embryos
(CDC, 2012). However, the discovery of misattributed paternity—in
which the presumed biological father of a patient is discovered not to
be the father—is still the most common scenario, with rates of
occurrence estimated to be between 0.8 to 30% (Bellis et al., 2005).
This paper discusses misattributed paternity speciﬁcally; similar
arguments would apply to alternative scenarios such as unanticipated
consanguinity or misattributed maternity, as has been documented in
a case involving an IVF error.
There is no formal consensus on how to handle the discovery of
misattributed paternity. The few guidelines that exist are contradictory.
In 1983, the President's Commission for the Study of Ethical Problems in
Biomedical and Behavioral Research recommended that misattributed
paternity be disclosed to both partners; eleven years later, an Institute
of Medicine (IOM) committee suggested that: “on balance… informa-
tion on misattributed paternity be communicated to the mother, but
not be volunteered to the woman's partner.” (Commission et al.,
1983). A recent opinion paper from the American Society of Human
Genetics (ASHG) on the ethical, legal and psychosocial implications of
genetic testing in children and adolescents gave a nod to truthfulness
but came down on the side of nondisclosure to either parent: “While
honoring their broad responsibility to be truthful with patients and
their families, we recommend that health-care providers avoidthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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beneﬁt that outweighs the potential harms.” (Botkin et al., 2015).
From available surveys, it would appear that most genetic profes-
sionals agree with the IOM. In a survey of genetic counselors in 1989,
over 95% said they would not disclose misattributed paternity to the
father (Pencarinha et al., 1992). A survey of medical geneticists the
following year by Wertz et al. found an equally resounding 96% would
not tell the father when recessive disease testing indicated
misattributed paternity, most of them adding that they would opt to
tell the mother in private (Wertz and Fletcher, 1991; Wright et al.,
2002). Case reports suggest that decisions are made on a case-by-case
basis, taking into account pertinent speciﬁc details like the state of
existing relationships within the family and potential medical ramiﬁca-
tions of nondisclosure (Soderdahl et al., 2004). However, these studies
provide strong evidence that absent compelling reason to do otherwise,
clinicians in practice default to not telling the father as the safer
alternative.
Evidence is less conclusive regarding patient preferences and expec-
tations. The handful of studies that exist suggest that patients are more
likely than doctors to say that a man should be informed about paterni-
ty. In a 1993 survey of American patients, 75% said that a doctor should
disclose if a man inquires about paternity. Lyn Turney, in a 2005 article
in Qualitative Health Research, reported that Australians showed a
“higher-than-average” level of comfort with disclosure of misattributed
paternity to the presumptive biological father (Turney, 2005).
Modern technology has revitalized interest in this age-old question.
In a recent article for the Hastings Center Report, Amulya Mandava and
colleagues note that the growing number of genomic research studies
necessitates an ethics framework to determine if researchers ever
have a duty to disclose the incidental discovery of misattributed parent-
age to study participants (Mandava et al., 2015). Using a framework
they propose, the authors conclude that there is typically no such
duty, because a researcher's role-speciﬁc commitment to avoid the
hypothetical harms of disclosure is stronger than any duties they have
to realize its potential beneﬁts. In otherwords, providing a research par-
ticipant with accurate information about a diagnosis or reproductive
risk may or may not be valuable, but it is not a researcher obligation.
In the medical realm, where a clinician's duties of beneﬁcence and
honesty to patients are considerably stronger, recent reﬂection on the
disclosure of misattributed relationships has amounted to a doubling
down on the status quo. In a 2014 article in Pediatrics, Marissa Palmor
and Autumn Fiester acknowledge the limitations of informed consent
in the pediatric setting, when parents' attention “is not fully on the
ramiﬁcations of non-parentage but on the health of their child”, and
contend that it is unlikely to provide a thoughtful and trustworthy
measure of parents' interest in paternity testing. Instead, the authors
propose, all informed consent forms for genetic testing ofminors should
contain boilerplate language indicating an ironclad policy of nondisclo-
sure: “we advocate the incorporation of a new clause into the informed
consent forms for pediatric genetic testing that clearly states that any
incidental information about parentage will not be revealed, regardless
of the result (Palmor and Fiester, 2014)”
3. New contextual considerations in favor of disclosure
Palmor and Fiester's argument in favor of nondisclosure as a policy is
based on the assumption that the potential harms of disclosure out-
weigh the potential beneﬁts. They argue that increasing use of genetic
testing will lead to more cases of misattributed paternity, and over-
whelm our current case-by-case model. “The incidental discovery of
nonparentage either burdens individual providers with the agonizing
and near-impossible task of weighing the pros and cons of disclosure
in the particular case or prompts the providers to call a consult with
the institution's ethics service so that the ethics committee can engage
in an assessment of those risks and beneﬁts. Case-by-case decision-
making…is not a satisfactory solution to this ever-increasing clinicaloccurrence because it undermines consistency, transparency and
uniformity across the institution or practice.”
Although this blanket stance may seem like an attractive option in
that it simpliﬁes a complex situation, new circumstances enabled by
modern technology warrant a careful reconsideration. Consider the
classic scenario Turney presented to her focus groups and survey
participants: a mother, a father and a child with recessive disease,
where tests results showed one deleterious allele in the child that
matched the mother and a second deleterious allele in the child that
did not match the father. Among the challenges that have been associ-
ated with such cases is the vanishingly rare but real possibility of a
new mutation. It is not a good thing to tell people they are mistaken
about the paternity of their child; it is an even worse thing to make
that suggestion and bewrong. Presumably, the possibility of a newmu-
tation, however rare, gave clinicians another reason not to reveal
misattributed paternity.
Modern tests that interrogatemultiple sites throughout the genome,
or the genome as a whole, offer no such room for temporizing. Many
new tests, including cell-free fetal DNA (cffDNA) testing and parental
follow-up testing to determine the clinical signiﬁcance of a variant of
uncertain signiﬁcance identiﬁed in a child regularly require maternal
and paternal DNA for comparative purposes and can reveal much
more information about the degree of genetic relationship between
two individuals. Clinical use of whole exome sequencing (WES) is also
enhanced by the use of maternal and paternal DNA. In a UCLA report
on their initial experience with WES, diagnostic yield was 22% without
parental DNA, and 31% for trios (mother, father and child) (Levenson,
2015). Indications long known to produce ﬁndings of misattributed pa-
ternity, such as recessive disease carrier testing and haplotype testing
for organ donation, are all increasing in frequency. We are entering an
era of both greater certainty in and greater opportunity for the discovery
of misattributed paternity as the number and type of tests available and
the use of those tests continue to rise year over year.
At the same time, a universal policy of nondisclosure presumes that
disclosure is reliably in the hands of the clinician. It is not. By federal law,
patients (or their parents and guardians) have a right to all test results.
It is not safe to assume that patients or family members will not be able
to deduce the possibility or even the certainty of misattributed
biological relationships on their own. If it does not happen at the time
of testing, it may happen down the road. Strategies for nondisclosure
often rely heavily on limited genetic literacy. In Wertz's 1990 study,
20% of geneticists said that they would “fudge the issue,” and 13% said
that theywould tell the couple that theywere “both genetically respon-
sible.” Lies, evasions and artful, tactful lack of communication may or
may not succeed in keeping the secret at the time of testing. New
information, new suspicions, more time to think, access to the internet,
and possibly even a much hoped-for increase in genetic literacy could
all undermine the effectiveness of that approach over time.
The idea of universal nondisclosure assumes a passivity on the part of
patients that is backward-looking, and not appropriate to an age where
many people are actively engaged in their healthcare decision-making
andhave access to all the resources of the internet. If an individual realizes
what the test indicates despite nondisclosure, the downside to nondisclo-
sure is not only a potential loss of trust, but also a loss of any discussion,
counseling or support the clinician might have been able to offer.
Genetic testing is no longer conﬁned to the clinical realm. As Dena
Davis points out in her 2014 article, “The Changing Face ofMisidentiﬁed
Paternity,” the use of direct-to-consumer paternity tests has risen steep-
ly worldwide, as cost has decreased and availability widened (Davis,
2007). Recreational testing can reveal misattributed paternity inciden-
tally as well as by design. In the U.S. alone, millions of people have
used genetic testing from companies such as Ancestry.com and
23andMe that provide information on genealogy and ethnicity.
‘Relative-ﬁnder’ services that indicate degree of kinship can expose
family secrets, as can SNP data that a variety of companies make avail-
able to their clientele.
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misattributed biological relationships, and so can unexpected results
among other members of the family, such as individuals raised as sib-
lings who turn out to be biological half siblings, or presumptive cousins
who are biologically unrelated. Anecdotal reports have surfaced with
the rising popularity of genealogy testing. Attention was drawn to the
topic in 2014 by a Vox media article entitled, “With genetic testing, I
gave my parents the gift of divorce (Vox Media, 2014).” Private reports
complement this very public example. In 2013, a geneticist in Long
Island got a strange question from a patient interested in conﬁrming
his own interpretation of a report he had received from 23andMe. The
company had identiﬁed a woman as his granddaughter, based on a
25%match in variable sites. Problematically, he was in his early thirties,
and thewomanwas only one year his junior. Since hismother had done
23andMe testing as well, he was able to determine that all the sites
where theymatchedwere paternal in origin. The youngwoman, enthu-
siastic at ﬁrst about exploring the connection, had ceased to return his
emails. “Could this individual be his half sister?” the patient asked
(Personal communication, 2014).
Today, in the event of nondisclosure, it is reasonable to anticipate
that either recreational testing or future medical testing could reveal a
misattributed biological relationship at a later date, and might lead to
some Monday-morning quarterbacking about the justiﬁability of a
clinician's decision not to disclose. Now and in the future, information
about misattributed relationships will not remain buried in the
clinician's own ﬁles as it would have years ago. Rather, it will be
enshrined in the electronic health record (EHR). Most physicians now
use the EHR (Furukawa et al., 2014), with government penalties in the
form of docked reimbursements for those who do not; studies show a
ﬁve-fold increase in the use of electronic health records in hospitals
from 2008 to 2014 (Ofﬁce of the National Coordinator for Health
Information Technology). The information is therefore permanently
available for anyone accessing the EHR, and it cannot be ﬂagged or
marked to warn future medical caregivers of what has not been com-
municated. A decision not to disclose information about amisattributed
biological relationship today rests uneasily on the assumption that dis-
covery will not take place at a later date, and essentially places a time
bomb in the medical record.
A greater risk of subsequent discovery provides several arguments
for disclosure. The ﬁrst is that it raises a potential new sort of liability
for genetic professionals. It is easy to imagine that some men, perhaps
most men, ﬁnding out that they are not the biological father of their
child and deducing that this information had been withheld, would be
angry. The fact that their anger is both foreseeable and understandable
may constitute in itself an argument that nondisclosure is unethical. At a
minimum, it compromises the perception of medical professionals as
truthful and neutral providers of information. Finally, the risk for later
discovery diminishes the value of nondisclosure, since the conse-
quences for the family are more likely to be delayed than avoided.
Most signiﬁcantly, nondisclosure blinds families to information
about biological parentage that has medical signiﬁcance. An afﬁrmative
promise as suggested by Fiester and Palmor that information relevant to
parentage will never be revealed sets up a conﬂict in those cases where
clear medical ramiﬁcations would tip the balance in favor of disclosure.
There are many clinical situations in which disclosure could bemandat-
ed onmedical grounds. Itmay be in the best interests of the child to ﬁnd
and test his or her biological father. It may be that either one or both
parents are using these test results to guide decisions about whether
or not to have more children, or what testing is required for a pregnan-
cy. It may be that other family members are undergoing expensive or
potentially hazardous risk assessments that are not necessary, and/or
that biological relatives are not getting surveillance they should be get-
ting. Clinicians may attempt to engineer the correct outcome without
giving enough explanation to reveal a misattributed biological relation-
ship, but misdirection and lack of transparency are hardly bedrocks on
which to base policy for clinical practice.The full medical implications can go far beyond the immediate ram-
iﬁcations. Discussions of misattributed paternity consistently dismiss
the medical value of information on parentage (Christenhusz et al.,
2013; Jackson et al., 2012), but this is contrary to the direction in
which medicine has been moving, and contrary to the most recent
thinking in comparable areas such as adoption and gamete donation,
where there is increasing emphasis on the need for accurate family
health history information. Many countries, including Sweden,
Norway and the United Kingdom, have restricted or forbidden the use
of anonymous gamete donation because of what they recognize as
every child's ‘right to know’ his or her genetic heritage (Ravelingien
and Pennings, 2013).
The expanded use of genetic testing across multiple medical disci-
plines increases the already-important role that family health history
information plays in risk assessment, diagnosis, prognosis and repro-
ductive decision-making. In specialties as diverse as cardiology, cancer
and ophthalmology, family history is used to determine who gets test-
ing and to qualify and interpret the results. Gaps in family health history
are a subject of concern for adoptees.Molecular genetic testing has been
shown to be of use for adoptees to ﬁll in blanks, but with the under-
standing that genetic analysis is “unlikely to provide a replacement for
family history when available (May et al., 2015).”
Misattributed paternity is far more problematic in that there it not
only leaves a gap in family health history information on the paternal
side, butﬁlls that gapwithmisinformation. Inaccurate family health his-
tory can be falsely alarming or falsely reassuring, and it can affect the
child and other family members. Clinicians making the argument that
there is no compelling reason to reveal misattributed paternity imply
that a lifetime of living with and imparting inaccurate family health his-
tory will not impact medical care. This is an uncomfortable position for
genetics professionals. It should give them pause.
4. Arguments against disclosure: the need for evidence
The most compelling reason not to reveal information about
misattributed relationships is to avoid the potential harms that may re-
sult from disclosure. Undeniably, revelations aboutmisattributed pater-
nity will create short-term upheavals. What the long-term effects may
be are more difﬁcult to parse. It is fair to speculate that disclosure may
harm the child by harming the family unit; it is also fair to speculate
that disclosure might have other downstream consequences, such as
allowing the child a relationship with their biological parent. The
point is, we don't know how this information will affect the child's
life, only that it will affect the child's life. In a pediatric setting, the pri-
mary objective is the best interest of the child. A common and credible
argument for nondisclosure in the case of misattributed paternity is
that it is necessary to preserve the family unit and the child's relation-
ship with the father (assuming such a relationship exists). This argu-
ment makes a couple of assumptions, neither of which is completely
reliable. One, it assumes that disclosure would destroy the family, and
that non-disclosure would preserve it. Two, it assumes that this family
and this relationship, as constituted, represent the child's best chance
at a happy home life.
Another frequently cited reason to refrain from disclosure is to re-
spect patient conﬁdentiality. In the Wertz survey, a majority of medical
geneticists agreedwith the statement that disclosure would ‘violate the
mother's expectation of conﬁdentiality’. The misattributed paternity
scenario, however, is not what we typically think of when we discuss
doctor-patient conﬁdentiality. In fact, if the medical caregivers are
struggling to decide who to tell, it implies that either the mother
knew and chose not to conﬁde in her medical team or that she did not
know, in which case she could not conﬁde. Either way, she has not con-
ﬁded anything and therefore cannot have an expectation of conﬁdenti-
ality in the traditional sense. Nor are they revealing her test results
without permission, since it is the father and the child's test results
that are at issue. Using the word ‘conﬁdentiality’ is laying claim to
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in extraordinary circumstances. But both the mother and the father
have rights in this scenario, and there is no obvious reason to prioritize
her right to keep a secret over his right to know.
The decision to err on the side of protecting the status quo is obvi-
ously more comfortable for many medical professionals, and may be
the easier option, but it has a cost for the family as well. Current policy
is based on assumptions and could beneﬁt from empirical research on
the aftereffects of disclosure in a variety of settings. Not only would
such data reveal what is morally at stake for patients and their families
as a consequence of disclosure, it would furnish clinicians with an
evidence base to rely on when judging the likelihood that disclosure
will result in harms that outweigh its beneﬁts.
5. The necessity of a nuanced approach
The transition into the genomic era brings together a number of
trends: better tests, more tests, and more of a role for genetic informa-
tion (including family health history information) in optimizingmedical
care. All of these changes argue against a default assumption that clini-
cians should not disclose a misattributed biological relationship if they
have a choice. But the changes, while profound, are not always decisive.
Additionally, we are aware that to a large extent the arguments we
make here are grounded in culturally speciﬁc legal and social norms,
and may not adequately reﬂect the extent to which a revelation of
misattributed paternity poses a risk to mother and child in other
settings.
A single, universal policy for handling the discovery of misattributed
biological relationships is an alluring ideal, providing a quick, clear an-
swer to a thorny and complex problem. Unfortunately, the weight of
speciﬁc details, such as immediate medical consequences of nondisclo-
sure or the potential for serious and imminent physical harm, requires
the exercise of clinical judgment informed by evidence, and is likely to
resist any attempt to preempt our current case-by-case model of
decision-making. No dilemma worth its salt can be solved by a single
line in a standard informed consent document. The discovery of
misattributed biological relationships is a clinical challenge, and it will
continue to be a clinical challenge.
The likelihood of later discovery and the increasing use of family
health history information in clinical care suggest that the clinician's im-
pulse to default in favor of nondisclosure is a less viable strategy in the
genomic age. Though it is well intended, medicine is likely to move
against this form of paternalism as it has moved against others.
Among patients, there is more access to information andmore expecta-
tion of access to information; nondisclosure violates the norms of truth-
fulness and transparency that people have come to expect in medical
settings. If discovered – and it is far more likely than ever before to be
discovered – it will raise ethical and legal challenges.
To some extent, the question of whether parents have a reasonable
expectation of disclosure depends on how those expectations were
managed in pretest counseling. However, while pretest counseling can
alert parents to the possibility that genetic testing will uncover
misattributed relationships, it cannot absolve clinicians of allresponsibility to inform families truthfully of the meaning and conse-
quences of their results. In an age where we are counseling our patients
to empower themselves by understanding their own health risks and
susceptibilities, we cannot rely on misdirection and sleight of hand to
hide pertinent facts fundamental to their biological selves. The changes
associated with genomic testing and related changes increase the risks
associated with nondisclosure of misattributed paternity and decrease
the beneﬁts. Ethically, legally and practically, genetic professionals and
those who advise them should consider a greater emphasis on the
value of disclosure.
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